Publicacións nas que colabora con José Manuel Martín Villa (11)

2024

  1. The Immune Modulation HLA-G*01:01:01 Full Allele Is Associated with Gastric Adenocarcinoma Development

    International Journal of Molecular Sciences, Vol. 25, Núm. 19

2022

  1. Higher prevalence of LAP+ (Latency TGFβ-Associated Peptide) T cells at the tissue level in patients with early gastric cancer

    Cellular Immunology, Vol. 382

2021

  1. A reliable and standardizable differential PCR and qPCR methodology assesses HER2 gene amplification in gastric cancer

    Biology, Vol. 10, Núm. 6

  2. HLA-G 3’UTR Polymorphisms Are Linked to Susceptibility and Survival in Spanish Gastric Adenocarcinoma Patients

    Frontiers in Immunology, Vol. 12

  3. TGFB1 polymorphisms and TGF-β1 plasma levels identify gastric adenocarcinoma patients with lower survival rate and disseminated disease

    Journal of Cellular and Molecular Medicine, Vol. 25, Núm. 2, pp. 774-783

2008

  1. Herpesvirus saimiri transformation may help disclose inherent functional defects of mucosal T lymphocytes in patients with gastric adenocarcinoma

    Immunology and Cell Biology, Vol. 86, Núm. 3, pp. 289-291

2007

  1. FcRγ chain does not replace CD3ζ chain in CD3ζ-deficient T lymphocytes of patients with gastric adenocarcinoma

    Molecular Immunology, Vol. 44, Núm. 9, pp. 2400-2405

2006

  1. Erratum to "Defective CD3ζ chain expression in Herpesvirus saimiri (HVS)-derived T-cell lines in gastric adenocarcinoma" [Cell. Immunol. 238 (2005) 113-122] (DOI:10.1016/j.cellimm.2006.02.007)

    Cellular Immunology

  2. Expression of CD45 and proliferative response to CD3 as suitable classification markers of patients with gastric adenocarcinoma

    Cancer Immunology, Immunotherapy, Vol. 55, Núm. 6, pp. 744-748

2005

  1. Defective CD3ζ chain expression in Herpesvirus saimiri (HVS)-derived T-cell lines in gastric adenocarcinoma

    Cellular Immunology, Vol. 238, Núm. 2, pp. 113-122

2003

  1. Intrinsic defects explain altered proliferative responses of T lymphocytes and HVS-derived T-cell lines in gastric adenocarcinoma

    Cancer Immunology, Immunotherapy, Vol. 52, Núm. 11, pp. 708-714